- Product Details
Keywords
- Favipiravir
- T-705
- T705
Quick Details
- ProName: T 705
- CasNo: 259793-96-9
- Appearance: White to off-white powder
- Application: For research use only
- DeliveryTime: 7 days
- ProductionCapacity: 10 Kilogram/Month
- Purity: >95%
- LimitNum: 1 Gram
Superiority
BOC Sciences is committed to supplying cost-effective products and services. We provide T 705 (Cas No:259793-96-9). Favipiravir, also known as T-705 or Avigan, is an experimental antiviral drug being developed by Toyama Chemical of Japan with activity against many RNA viruses. Like some other experimental antiviral drugs (T-1105 and T-1106), it is a pyrazinecarboxamide derivative. Favipiravir is active against influenza viruses, West Nile virus, yellow fever virus, foot-and-mouth disease virus as well as other flaviviruses, arenaviruses, bunyaviruses and alphaviruses. Activity against enteroviruses and Rift Valley fever virus has also been demonstrated. More information, please visit the website:#
Details
- Product Name
- T 705
- Catalog Number
- 259793-96-9
- Synonyms
- Favipiravir; T-705; T705
- CAS Number
- 259793-96-9
- Description
- Favipiravir, also known as T-705 or Avigan, is an experimental antiviral drug being developed by Toyama Chemical of Japan with activity against many RNA viruses. Like some other experimental antiviral drugs (T-1105 and T-1106), it is a pyrazinecarboxamide derivative. Favipiravir is active against influenza viruses, West Nile virus, yellow fever virus, foot-and-mouth disease virus as well as other flaviviruses, arenaviruses, bunyaviruses and alphaviruses. Activity against enteroviruses and Rift Valley fever virus has also been demonstrated.
- Molecular Weight
- 157.1
- Molecular Formula
- C5H4FN3O2
- Quantity
- Grams-Kilos
- Quality Standard
- Enterprise Standard